Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1998 Mar;77(6):1015–1020. doi: 10.1038/bjc.1998.167

Cross-reactivity between Candida albicans and human ovarian carcinoma as revealed by monoclonal antibodies PA10F and C6.

J Schneider 1, D Moragues 1, N Martínez 1, H Romero 1, E Jimenez 1, J Pontón 1
PMCID: PMC2150113  PMID: 9528850

Abstract

Summary Antibodies against Candida albicans antigenic determinants have been reported to cross-react with human tumour cells. We have found that two monoclonal antibodies, C6 and PA1OF, developed at our laboratory against C. albicans antigenic determinants, cross-react with human ovarian cancer on Western blots and immunohistochemistry. We have subsequently used one of them, PA10OF, to test by means of immunohistochemistry a series of 37 human ovarian carcinomas. Out of 37 tumours, 25 (67.6%) expressed the antigen recognized by PA1OF. The reactivity, however, was concentrated on the subgroup of particularly aggressive, invasive carcinomas in advanced stages of the disease (19 out of 24 positive), whereas the antigen was expressed significantly less (P=0.0007) in the subgroup of much less aggressive stage I tumours of low malignant potential, also called borderline carcinomas (2 out of 13 positive). This cross-reactivity between C. albicans and ovarian carcinoma seems to be attributable to a common antigenic determinant related to tumour aggressiveness.

Full text

PDF
1015

Images in this article

1016Figure 1
on p.1016
1016Figure 2
on p.1016
1017Figure 3
on p.1017

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Fuller K. J., Issels R. D., Slosman D. O., Guillet J. G., Soussi T., Polla B. S. Cancer and the heat shock response. Eur J Cancer. 1994;30A(12):1884–1891. doi: 10.1016/0959-8049(94)00362-9. [DOI] [PubMed] [Google Scholar]
  2. Hashizume S., Kamei M., Mochizuki K., Sato S., Kuroda K., Kato M., Yasumoto K., Nakahashi H., Hirose H., Tai H. Serodiagnosis of cancer by using Candida cytochrome c recognized by human monoclonal antibody HB4C5. Hum Antibodies Hybridomas. 1991 Jul;2(3):142–147. [PubMed] [Google Scholar]
  3. Kawamoto S., Hashizume S., Katakura Y., Tachibana H., Murakami H. Molecular cloning of yeast cytochrome c-like polypeptide expressed in human lung carcinoma: an antigen recognizable by lung cancer-specific human monoclonal antibody. In Vitro Cell Dev Biol Anim. 1995 Oct;31(9):724–729. doi: 10.1007/BF02634095. [DOI] [PubMed] [Google Scholar]
  4. Kimura E., Enns R. E., Alcaraz J. E., Arboleda J., Slamon D. J., Howell S. B. Correlation of the survival of ovarian cancer patients with mRNA expression of the 60-kD heat-shock protein HSP-60. J Clin Oncol. 1993 May;11(5):891–898. doi: 10.1200/JCO.1993.11.5.891. [DOI] [PubMed] [Google Scholar]
  5. Lindquist S., Craig E. A. The heat-shock proteins. Annu Rev Genet. 1988;22:631–677. doi: 10.1146/annurev.ge.22.120188.003215. [DOI] [PubMed] [Google Scholar]
  6. Mathur S., Melchers J. T., 3rd, Ades E. W., Williamson H. O., Fudenberg H. H. Anti-ovarian and anti-lymphocyte antibodies in patients with chronic vaginal candidiasis. J Reprod Immunol. 1980 Dec;2(5):247–262. doi: 10.1016/0165-0378(80)90038-8. [DOI] [PubMed] [Google Scholar]
  7. Polonelli L., Gerloni M., Conti S., Fisicaro P., Cantelli C., Portincasa P., Almondo F., Barea P. L., Hernando F. L., Ponton J. Heat-shock mannoproteins as targets of secretory IgA in Candida albicans. J Infect Dis. 1994 Jun;169(6):1401–1405. doi: 10.1093/infdis/169.6.1401. [DOI] [PubMed] [Google Scholar]
  8. Ponton J., Jones J. M. Analysis of cell wall extracts of Candida albicans by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blot techniques. Infect Immun. 1986 Sep;53(3):565–572. doi: 10.1128/iai.53.3.565-572.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ponton J., Marot-Leblond A., Ezkurra P. A., Barturen B., Robert R., Senet J. M. Characterization of Candida albicans cell wall antigens with monoclonal antibodies. Infect Immun. 1993 Nov;61(11):4842–4847. doi: 10.1128/iai.61.11.4842-4847.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Schneider J., Rubio M. P., Barbazán M. J., Rodriguez-Escudero F. J., Seizinger B. R., Castresana J. S. P-glycoprotein, HER-2/neu, and mutant p53 expression in human gynecologic tumors. J Natl Cancer Inst. 1994 Jun 1;86(11):850–855. doi: 10.1093/jnci/86.11.850. [DOI] [PubMed] [Google Scholar]
  11. Smail E. H., Jones J. M. Demonstration and solubilization of antigens expressed primarily on the surfaces of Candida albicans germ tubes. Infect Immun. 1984 Jul;45(1):74–81. doi: 10.1128/iai.45.1.74-81.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Sundstrom P. M., Kenny G. E. Characterization of antigens specific to the surface of germ tubes of Candida albicans by immunofluorescence. Infect Immun. 1984 Mar;43(3):850–855. doi: 10.1128/iai.43.3.850-855.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Sundstrom P., Aliaga G. R. A subset of proteins found in culture supernatants of Candida albicans includes the abundant, immunodominant, glycolytic enzyme enolase. J Infect Dis. 1994 Feb;169(2):452–456. doi: 10.1093/infdis/169.2.452. [DOI] [PubMed] [Google Scholar]
  14. Yasumoto K., Setoguchi Y., Kamei M., Kato M., Nomoto K., Murakami H., Hashizume S. Cancer-specific binding of a mouse MAb vs. Candida krusei cytochrome c: an antigen recognized by a cancer-associated human MAb HB4C5. Hum Antibodies Hybridomas. 1993 Oct;4(4):186–189. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES